by Guest Contributer | Jul 15, 2024 | Advocacy, Drug Legislation, Feature, Marijuana & CBD, Workplace Safety
By Bill Current, Founder of the Current Consulting Group It’s been said that elections have consequences, including unintended consequences that can be harmful, nonetheless. The Drug Enforcement Administration (DEA), at President Biden’s direction, intends to...
by NDASA | Jun 12, 2024 | Drug & Alcohol Testing, Feature, Industry News
Reprinted article courtesy of Quest Diagnostics, a leading provider of diagnostic information services. Key Findings The overall drug positivity held steady at historically high rates in 2023, while marijuana positivity continued an upward climb in the general U.S....
by Guest Contributer | Apr 2, 2021 | Drug Legislation, Feature, Marijuana & CBD
By NDASA member William Judge, JD, LL.M., founder of the Drug Screening Compliance Institute and an attorney with more than three decades of experience in drug screening compliance. New York, this week, became the 15th state (in addition to Washington D.C.) to...
